Literature DB >> 33922329

Macrophages and Immune Responses in Uterine Fibroids.

Alessandro Zannotti1,2, Stefania Greco2, Pamela Pellegrino2, Federica Giantomassi3, Giovanni Delli Carpini1, Gaia Goteri3, Andrea Ciavattini1, Pasquapina Ciarmela2.   

Abstract

Uterine fibroids represent the most common benign tumors of the uterus. They are considered a typical fibrotic disorder. In fact, the extracellular matrix (ECM) proteins-above all, collagen 1A1, fibronectin and versican-are upregulated in this pathology. The uterine fibroids etiology has not yet been clarified, and this represents an important matter about their resolution. A model has been proposed according to which the formation of an altered ECM could be the result of an excessive wound healing, in turn driven by a dysregulated inflammation process. A lot of molecules act in the complex inflammatory response. Macrophages have a great flexibility since they can assume different phenotypes leading to the tissue repair process. The dysregulation of macrophage proliferation, accumulation and infiltration could lead to an uncontrolled tissue repair and to the consequent pathological fibrosis. In addition, molecules such as monocyte chemoattractant protein-1 (MCP-1), granulocyte macrophage-colony-stimulating factor (GM-CSF), transforming growth factor-beta (TGF-β), activin A and tumor necrosis factor-alfa (TNF-α) were demonstrated to play an important role in the macrophage action within the uncontrolled tissue repair that contributes to the pathological fibrosis that represents a typical feature of the uterine fibroids.

Entities:  

Keywords:  ECM; inflammatory process; macrophages; pathological fibrosis; tissue repair; uterine fibroids

Year:  2021        PMID: 33922329     DOI: 10.3390/cells10050982

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  158 in total

1.  Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection.

Authors:  Elias A Said; Franck P Dupuy; Lydie Trautmann; Yuwei Zhang; Yu Shi; Mohamed El-Far; Brenna J Hill; Alessandra Noto; Petronela Ancuta; Yoav Peretz; Simone G Fonseca; Julien Van Grevenynghe; Mohamed R Boulassel; Julie Bruneau; Naglaa H Shoukry; Jean-Pierre Routy; Daniel C Douek; Elias K Haddad; Rafick-Pierre Sekaly
Journal:  Nat Med       Date:  2010-03-07       Impact factor: 53.440

2.  Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium.

Authors:  B Viville; D S Charnock-Jones; A M Sharkey; B Wetzka; S K Smith
Journal:  Hum Reprod       Date:  1997-04       Impact factor: 6.918

Review 3.  Preoperative medical therapy before surgery for uterine fibroids.

Authors:  Anne Lethaby; Lucian Puscasiu; Beverley Vollenhoven
Journal:  Cochrane Database Syst Rev       Date:  2017-11-15

4.  A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas.

Authors:  Tongsheng Wang; Xinmin Zhang; Laura Obijuru; Jordan Laser; Virginie Aris; Peng Lee; Khush Mittal; Patricia Soteropoulos; Jian-Jun Wei
Journal:  Genes Chromosomes Cancer       Date:  2007-04       Impact factor: 5.006

5.  A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy.

Authors:  A J Friedman; M S Rein; D Harrison-Atlas; J M Garfield; P M Doubilet
Journal:  Fertil Steril       Date:  1989-11       Impact factor: 7.329

Review 6.  Uterine fibroids.

Authors:  E A Stewart
Journal:  Lancet       Date:  2001-01-27       Impact factor: 79.321

7.  Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women.

Authors:  Minnie Malik; John Norian; Desirée McCarthy-Keith; Joy Britten; William H Catherino
Journal:  Semin Reprod Med       Date:  2010-04-22       Impact factor: 1.303

8.  Development of the selective progesterone receptor modulator CDB-2914 for clinical indications.

Authors:  Diana L Blithe; Lynnette K Nieman; Richard P Blye; Pamela Stratton; Maureen Passaro
Journal:  Steroids       Date:  2003-11       Impact factor: 2.668

9.  Matrix metalloproteinases of human leiomyoma in various stages of tumor growth.

Authors:  Małgorzata Wolańska; Krzysztof Sobolewski; Edward Bańkowski; Stefan Jaworski
Journal:  Gynecol Obstet Invest       Date:  2004-03-05       Impact factor: 2.031

Review 10.  Tissue-resident macrophages.

Authors:  Luke C Davies; Stephen J Jenkins; Judith E Allen; Philip R Taylor
Journal:  Nat Immunol       Date:  2013-09-18       Impact factor: 25.606

View more
  6 in total

Review 1.  Importance of Fibrosis in the Pathogenesis of Uterine Leiomyoma and the Promising Anti-fibrotic Effects of Dipeptidyl Peptidase-4 and Fibroblast Activation Protein Inhibitors in the Treatment of Uterine Leiomyoma.

Authors:  Anusha Shreenidhi Bhat; Ningthoujam Anirudh Singh; Emdormi Rymbai; Swapna Birendra; Saravanan Jayaram; Divakar Selvaraj
Journal:  Reprod Sci       Date:  2022-08-15       Impact factor: 2.924

2.  Different DNA methylome, transcriptome and histological features in uterine fibroids with and without MED12 mutations.

Authors:  Ryo Maekawa; Shun Sato; Tetsuro Tamehisa; Takahiro Sakai; Takuya Kajimura; Kotaro Sueoka; Norihiro Sugino
Journal:  Sci Rep       Date:  2022-05-26       Impact factor: 4.996

Review 3.  Dietary Natural Compounds and Vitamins as Potential Cofactors in Uterine Fibroids Growth and Development.

Authors:  Iwona Szydłowska; Jolanta Nawrocka-Rutkowska; Agnieszka Brodowska; Aleksandra Marciniak; Andrzej Starczewski; Małgorzata Szczuko
Journal:  Nutrients       Date:  2022-02-09       Impact factor: 5.717

4.  The association between chronic endometritis and uterine fibroids.

Authors:  Roya Kabodmehri; Atoosa Etezadi; Seyedeh Hajar Sharami; Mandana Mansour Ghanaei; Fatemeh Hosseinzadeh; Seyedeh Fatemeh Dalil Heirati; Zahra Pourhabibi
Journal:  J Family Med Prim Care       Date:  2022-02-16

5.  Analysis of Clinical Efficacy of Laparoendoscopic Single-Site Surgery for Uterine Fibroids.

Authors:  Wei Zhu; Shiqin Mao; Yan Chen; Xiang Kong
Journal:  J Healthc Eng       Date:  2022-04-11       Impact factor: 3.822

6.  Correlation Between Platelet-Lymphocyte Ratio and Neutrophil-Lymphocyte Ratio in Patients with Uterine Leiomyoma: A Cross-Sectional Study.

Authors:  Yanan Duan; Yiqing Peng; Xiuling Shi; Ying Zhao; Kunyan Liu; Runsheng Zhou; Cunxu Peng
Journal:  J Oncol       Date:  2022-08-11       Impact factor: 4.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.